BioReference Laboratories, Inc. Announces Record Annual Revenues and Record Revenues and Operating Income for Q4FY05; Operating income for Q4FY05 tops Q4FY04 by 16%.

Extract


BioReference Laboratories, Inc. Announces Record Annual Revenues and Record Revenues and Operating Income for Q4FY05; Operating income for Q4FY05 tops Q4FY04 by 16%.

ELMWOOD PARK, N.J. -- Fourth graph, fourth sentence of release should read: This clearly impacted our net profits; when compared to the previous reimbursement rates, our top line and operating income were both reduced by approximately $5 to $6 million dollars by Medicare and other payers (sted This clearly impacted our net profits; when compared to the previous reimbursement rates, our top and bottom line were both reduced by approximately $5 to $6 million dollars by Medicare and other payers). Also, in the Statements of Operations under the Year Ended October 31, Cost of Sales heading, the figure should read: 83,352 (sted 82,352).

The corrected release reads:

BIOREFERENCE LABORATORIES, INC. AN...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company